- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03618498
Internal Limiting Membrane Flaps for Coexistent Macular Hole and Retinal Detachment (ILMFCMHRDPDR)
August 7, 2018 updated by: San Ni Chen, Changhua Christian Hospital
Internal Limiting Membrane Flaps for Coexistent Macular Hole and Retinal Detachment in Eyes of Proliferative Diabetic Retinopathy
Purpose: To evaluate the logical surgical approaches in closing macular holes in eyes of proliferative diabetic retinopathy with retinal detachment
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
High MH closure rate can be achieved.
Other than high myopia, MH with RD may appear in several conditions, such as severe vitreomacular traction, proliferative diabetic retinopathy (PDR).clinical
charts were reviewed of patients of proliferative diabetic retinopathy suffering from MH with RD who were treated with vitrectomy combined with inverted epiretinal ILM flap,inverted ILM flaps insertion techniques, or free ILM flaps.Standard 3-port 23 or 25 gauged pars plana vitrectomy was performed.
After core vitrectomy, anterior-posterior oriented tractions as well as all fibrovascular tissues were removed as thoroughly as possible.The patients were kept in a facedown position overnight and were allowed to take any positions except supine for approximately one week.Various surgical approaches utilizing in managing macular hole may effectively closing macular holes and reattach retina.
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Changhua, Taiwan
- Changhua Christian Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients were proliferative diabetic retinopathy suffering from MH with RD.
Exclusion Criteria:
- Patients were not proliferative diabetic retinopathy suffering from MH with RD.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Interventional Model: SEQUENTIAL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Patient accept surgery
Proliferative diabetic retinopathy suffering from MH with RD who were treated with vitrectomy combined with inverted epiretinal ILM flap,inverted ILM flaps insertion techniques, or free ILM flaps.
|
The ILM flap anchoring on the hole edge was inverted and covered the hole.Otherwise, temporal side ILM flap was used.
However, if the risk of ILM flipping back was judged to be high, ILM insertion instead of ILM hole coverage was adopted.If the size of the ILM flaps was judged inadequate, the double ILM insertion technique was used, done by adding a piece of previously obtained free ILM flap on top of the inverted ILM tissue until they were securely in place.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Wilcoxon Sign-Rank test
Time Frame: Baseline, 12 months.
|
A statistical comparison of average of two dependent samples
|
Baseline, 12 months.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Chen San-Ni, MD, Changhua Christian Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 7, 2018
Primary Completion (ACTUAL)
May 31, 2018
Study Completion (ACTUAL)
July 15, 2018
Study Registration Dates
First Submitted
July 23, 2018
First Submitted That Met QC Criteria
August 5, 2018
First Posted (ACTUAL)
August 7, 2018
Study Record Updates
Last Update Posted (ACTUAL)
August 8, 2018
Last Update Submitted That Met QC Criteria
August 7, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 180314
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Supporting Information Type
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Retinal Detachment
-
The S.N. Fyodorov Eye Microsurgery State InstitutionUnknownRhegmatogenous Retinal DetachmentRussian Federation
-
Meir Medical CenterUnknownRhegmatogenous Retinal DetachmentIsrael
-
University of Campinas, BrazilCompletedRhegmatogenous Retinal Detachment
-
Ain Shams UniversityNot yet recruitingRhegmatogenous Retinal Detachment
-
Shahid Beheshti University of Medical SciencesUnknownPseudophakic Retinal Detachment | Aphakic Retinal DetachmentIran, Islamic Republic of
-
Dar El Oyoun HospitalCairo UniversityCompletedRetinal Detachment Multiple BreaksEgypt
-
Universidade Federal do ParanáCompletedRhegmatogenous Retinal Detachment
-
Singapore National Eye CentreCompleted
-
Samsung Medical CenterCompletedRhegmatogenous Retinal Detachment
-
Vitreous -Retina- Macula Consultants of New YorkRegeneron PharmaceuticalsWithdrawnFibrovascular Pigment Epithelial DetachmentUnited States
Clinical Trials on ILM flaps insertion techniques or free ILM flaps.
-
National Taiwan University HospitalCompletedRetinal Detachment | High Myopia | Macular Holes